Saccharomyces Boulardii Drug Interactions, Uses, Effectiveness, Safety & More
What is this page for?
First and foremost: how Saccharomyces Boulardii interacts with medications. The heart of this page is the interaction list — every drug Saccharomyces Boulardii is known to interact with, and how serious each one is.
But these pages have grown well beyond that into a full monograph — what Saccharomyces Boulardii is, what people use it for and how strong the evidence is, its safety and side effects, and answers to the questions we’re asked most — written and reviewed by the clinical staff at HelloPharmacist. It’s educational information from our licensed clinical databases, not medical advice, and we don’t sell or endorse products. Our editorial policy
Check Saccharomyces Boulardii against your medication
Add one medicationSaccharomyces Boulardii Drug Interactions: The Bottom Line
From the HelloPharmacist Editorial Team · Updated July 2026Based on the available evidence, the overall risk of a clinically significant Saccharomyces Boulardii drug interaction appears low for most people. Every interaction on record is rated minor, with none rated moderate or major.
The only concern that stands out involves antifungal medications. Because Saccharomyces boulardii is itself a live yeast, taking an antifungal at the same time could kill many of the probiotic organisms and weaken its benefit. This is a theoretical concern, not one proven in people, and importantly the risk runs toward the supplement losing effect rather than the medication causing harm. Nothing in this profile points to problems with closely monitored medicines like blood thinners or diabetes drugs.
Although a few dozen medications appear on the interaction list, they all fall under this single antifungal concern, and none of them are expected to become more dangerous or less effective because of the probiotic. In short, the long list reflects one theoretical issue applied to many drugs, not many separate risks.
Based on HelloPharmacist’s Saccharomyces Boulardii interaction data and reviewed under our editorial standards.
Drugs that interact with Saccharomyces Boulardii
40 medications have a known interaction with Saccharomyces Boulardii, graded by severity. Select any drug for the full evidence-based detail.
Don’t want to scroll the list? Just ask.
Tell us the medications you take and we’ll check each one against Saccharomyces Boulardii using our pharmacist-reviewed interaction data.
AI summaries are generated from our Saccharomyces Boulardii interaction data for education only — always confirm with your pharmacist. How we use AI
No drugs match “”.
Amphotericin BAbelcet, AmBisome, Amphocil, Amphocin, Fungizone IV
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Amphotericin B interactionAnidulafunginEraxis
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Anidulafungin interactionBenzalkonium ChlorideZephiran
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Benzalkonium Chloride interactionBoric AcidBoric Acid, Boric acid ointment
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Boric Acid interactionButenafineMentax
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Butenafine interaction Butenafine drug page: uses, dosage & side effectsButoconazoleGynazole
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Butoconazole interactionCarbol-fuchsinCastellani Paint Modified
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Carbol-fuchsin interactionCaspofunginCancidas
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Caspofungin interaction Caspofungin drug page: uses, dosage & side effectsChlorhexidineBactoShield 2
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Chlorhexidine interactionChloroxineCapitrol
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Chloroxine interactionCiclopiroxLoprox
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Ciclopirox interactionClioquinolVioform
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Clioquinol interactionClotrimazoleGyne Lotrimin, Mycelex G Vaginal
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Clotrimazole interactionEconazoleSpectazole
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Econazole interaction Econazole drug page: uses, dosage & side effectsFluconazoleDiflucan, Diflucan Injection
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Fluconazole interaction Fluconazole drug page: uses, dosage & side effectsFlucytosineAncobon, Ancotil
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Flucytosine interactionGentian Violet (otc Drug)Gentian Violet
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Gentian Violet (otc Drug) interactionGriseofulvinFulvicin PG, Fulvicin-U/F, Grisactin, Grisactin Ultra
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Griseofulvin interaction Griseofulvin drug page: uses, dosage & side effectsHaloproginHalotex
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Haloprogin interactionIodine (prescription Drug)Iodine Tincture
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Iodine (prescription Drug) interactionIodine (topical)Iodine Tincture
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Iodine (topical) interactionIodoquinolYodoxin
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Iodoquinol interactionItraconazoleSporanox, Sporanox Injection, Tolsura
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Itraconazole interaction Itraconazole drug page: uses, dosage & side effectsKetoconazoleNizoral
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Ketoconazole interaction Ketoconazole drug page: uses, dosage & side effectsMicafunginMycamine
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Micafungin interactionMiconazoleAcorvio, Daktarin, Micatin, Monistat, Zeasorb-AF
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Miconazole interactionMiconazole, Zinc Oxide, PetrolatumVusion
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Miconazole, Zinc Oxide, Petrolatum interactionNaftifineNaftin
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Naftifine interaction Naftifine drug page: uses, dosage & side effectsNatamycinNatacyn
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Natamycin interactionNystatinMycostatin, Nilstat
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Nystatin interaction Nystatin drug page: uses, dosage & side effectsOteseconazoleVivjoa
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Oteseconazole interactionPovidone IodineBetadine drops
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Povidone Iodine interactionSertaconazoleErtaczo
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Sertaconazole interaction Sertaconazole drug page: uses, dosage & side effectsSulconazoleExelderm
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Sulconazole interaction Sulconazole drug page: uses, dosage & side effectsTerbinafineLamisil
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Terbinafine interaction Terbinafine drug page: uses, dosage & side effectsTerconazoleTerazole
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Terconazole interaction Terconazole drug page: uses, dosage & side effectsTioconazoleVagistat
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Tioconazole interactionTolnaftateTinactin
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Tolnaftate interaction Tolnaftate drug page: uses, dosage & side effectsUndecylenic AcidDesenex
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Undecylenic Acid interaction Undecylenic Acid drug page: uses, dosage & side effectsVoriconazoleVfend
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
Read the full Saccharomyces Boulardii + Voriconazole interaction Voriconazole drug page: uses, dosage & side effectsWhat Severity, Likelihood & Evidence Mean
Severity — How Serious It Can Be
- Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
- Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
- Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
- No known interaction. Checked against our sources with nothing documented — not the same as proven safety.
Likelihood — How Well It’s Documented
- Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
- Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
- Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Where This Data Comes From
- Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
- Each drug listed above links to the full report for that exact Saccharomyces Boulardii combination — clinical detail, likelihood, evidence level, and citations.
- Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The kinds of drugs Saccharomyces Boulardii affects
Every type of medication (drug category) Saccharomyces Boulardii is known to interact with. Open any category for the detail — or search your exact drug in the checker above.
Antifungals
Theoretically, taking antifungals with Saccharomyces boulardii might decrease the effectiveness of Saccharomyces boulardii.
S. boulardii is a live yeast. Therefore, simultaneously taking antifungals might kill a significant number of the organisms.
Saccharomyces Boulardii: Uses, Safety & Side Effects
Saccharomyces boulardii is a beneficial yeast used as a probiotic, with the strongest evidence for preventing and treating certain types of diarrhea, including antibiotic-associated diarrhea. It is generally well tolerated in healthy people, but those who are seriously ill or have weakened immune systems should avoid it because of rare but serious bloodstream infections. Talk with your pharmacist or doctor before starting it.

- Scientific name
- Saccharomyces cerevisiae var. boulardii
- Family
- Saccharomycetaceae
- Part used
- Whole yeast cells (probiotic microorganism)
- Common forms
- Capsules, tablets, powders (often sold as lyophilized/freeze-dried yeast)
- Acute diarrhea
- Antibiotic-associated diarrhea
- Traveler's diarrhea
- Preventing C. difficile recurrence
- General gut health
Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.
Generally safe for healthy adults but should be avoided by people who are critically ill or immunocompromised.
Insufficient reliable information available; avoid using.
Read the full pregnancy detailInsufficient reliable information available; avoid using.
Read the full breastfeeding detailPregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Overview
Saccharomyces boulardii is a type of yeast used as a probiotic. It is a strain closely related to Saccharomyces cerevisiae, the yeast used to make bread and beer, but it is considered non-pathogenic, meaning it does not normally cause illness in healthy people.
Unlike most probiotics, which are bacteria, S. boulardii is a yeast. This means it is not killed by antibiotics, which is one reason it is often used alongside antibiotic treatment. It is sold widely as capsules, tablets, and powders in pharmacies, health stores, and online.
People most commonly take it to help with digestive problems, especially different types of diarrhea.
How it works
S. boulardii is thought to work in several ways. It may help crowd out harmful microbes in the gut and interfere with their ability to attach to the intestinal lining. Laboratory studies suggest it can break down or neutralize certain toxins, such as those made by C. diff.
It may also support the gut barrier, help balance the immune response in the intestines, and encourage the production of helpful substances in the digestive tract. Because it is a yeast, it is naturally resistant to antibiotics, so it can stay active even while a person is taking them.
Many of these mechanisms come from laboratory and animal research, so the exact way it helps in people is not fully understood.
Does Saccharomyces Boulardii work?
How to read these evidence grades
Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.
Possibly Effective Antibiotic-associated diarrhea
Oral Saccharomyces boulardii seems to be beneficial for the prevention of antibiotic-associated diarrhea (AAD) in most patients.
Possibly Effective Clostridioides difficile infection
Oral Saccharomyces boulardii seems to be beneficial for preventing C. difficile infection. In combination with vancomycin or metronidazole, oral S. boulardii seems to be beneficial for preventing recurrence of C. difficile infection.
Possibly Effective Helicobacter pylori
Oral Saccharomyces boulardii seems to be beneficial for reducing adverse effects associated with standard therapy for H. pylori eradication. It is unclear if it is beneficial for increasing eradication rates.
Possibly Effective Necrotizing enterocolitis (NEC)
Oral Saccharomyces boulardii seems to reduce the risk of NEC in hospitalized preterm infants. However, guidance among regulatory agencies and clinical organizations varies.
Possibly Effective Rotaviral diarrhea
In children, oral Saccharomyces boulardii seems to reduce the duration of rotaviral diarrhea.
Possibly Effective Travelers' diarrhea
Most research suggests that oral Saccharomyces boulardii can help to reduce the risk of traveler's diarrhea.
Possibly Ineffective Sepsis
In preterm infants, oral Saccharomyces boulardii does not seem to be beneficial for sepsis prevention.
Also studied for 24 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Acne
It is unclear if oral Saccharomyces boulardii is beneficial for acne.
Insufficient Reliable Evidence To Rate Cholera
It is unclear if oral Saccharomyces boulardii is beneficial for cholera.
Insufficient Reliable Evidence To Rate Cognitive function
It is unclear if oral Saccharomyces boulardii is beneficial for cognitive function.
Insufficient Reliable Evidence To Rate Constipation
It is unclear if oral Saccharomyces boulardii is beneficial in children with constipation.
Insufficient Reliable Evidence To Rate Critical illness (trauma)
It is unclear if oral Saccharomyces boulardii is beneficial for reducing complications in critically ill, hospitalized patients.
Insufficient Reliable Evidence To Rate Crohn disease
It is unclear if oral Saccharomyces boulardii is beneficial for this condition.
Insufficient Reliable Evidence To Rate Cystic fibrosis
It is unclear if oral Saccharomyces boulardii is beneficial for cystic fibrosis.
Insufficient Reliable Evidence To Rate Exercise-induced muscle soreness
Oral Saccharomyces boulardii has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Heart failure
It is unclear if oral Saccharomyces boulardii is beneficial for heart failure.
Insufficient Reliable Evidence To Rate HIV/AIDS-related diarrhea
It is unclear if oral Saccharomyces boulardii is beneficial for this condition.
Insufficient Reliable Evidence To Rate Hypercholesterolemia
It is unclear if oral Saccharomyces boulardii is beneficial for hypercholesterolemia.
Insufficient Reliable Evidence To Rate Intestinal parasite infection
It is unclear if oral Saccharomyces boulardii is beneficial for intestinal parasite infection.
Insufficient Reliable Evidence To Rate Irritable bowel syndrome (IBS)
It is unclear if oral Saccharomyces boulardii is beneficial for IBS.
Insufficient Reliable Evidence To Rate Low birth weight
It is unclear if oral Saccharomyces boulardii is beneficial for growth in low birth weight infants.
Insufficient Reliable Evidence To Rate Neonatal jaundice
It is unclear if oral Saccharomyces boulardii is beneficial for neonatal jaundice prevention or treatment.
Insufficient Reliable Evidence To Rate Obesity
Oral Saccharomyces boulardii has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Periodontitis
Although there has been interest in using oral Saccharomyces boulardii for periodontitis, there is insufficient reliable information about the clinical effects of S. boulardii for this condition.
Insufficient Reliable Evidence To Rate Postoperative infection
It is unclear if oral Saccharomyces boulardii prevents postoperative infection.
Insufficient Reliable Evidence To Rate Postoperative recovery
It is unclear if oral Saccharomyces boulardii improves postoperative recovery.
Insufficient Reliable Evidence To Rate Small intestinal bacterial overgrowth (SIBO)
It is unclear if oral Saccharomyces boulardii is beneficial for SIBO.
Insufficient Reliable Evidence To Rate Ulcerative colitis
It is unclear if oral Saccharomyces boulardii is beneficial for ulcerative colitis.
Insufficient Reliable Evidence To Rate Urinary tract infections (UTIs)
Although there has been interest in using oral Saccharomyces boulardii for UTIs, there is insufficient reliable information about the clinical effects of S. boulardii for this condition.
Insufficient Reliable Evidence To Rate Vaginal candidiasis
Although there has been interest in using oral Saccharomyces boulardii for vaginal candidiasis, there is insufficient reliable information about the clinical effects of S. boulardii for this condition.
Insufficient Reliable Evidence To Rate Ventilator-associated pneumonia (VAP)
Oral Saccharomyces boulardii has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.
Safety & precautions
For most healthy adults and children, S. boulardii is generally well tolerated. However, there are important exceptions. People who are critically ill, have weakened immune systems, or have central venous catheters (IV lines) should avoid it. In these groups, there have been rare but serious cases of the yeast entering the bloodstream and causing infection (funginemia).
People with yeast allergies should also avoid it. Use caution if you have a serious underlying illness.
For pregnancy and breastfeeding, there is not enough reliable safety information, so it is best to avoid it unless your doctor advises otherwise. Always check with a pharmacist or doctor before giving probiotics to infants, the elderly, or anyone who is seriously ill.
Side effects
Side effects are usually mild and may include gas, bloating, or mild stomach upset, especially when first starting. These often improve over time.
The most serious, though rare, risk is a bloodstream infection (fungemia), which has mostly been reported in people who are critically ill, immunocompromised, or who have IV catheters. Signs of infection such as fever should be checked by a doctor right away.
If you have an allergic reaction (rash, itching, trouble breathing), stop taking it and seek medical help.
Saccharomyces Boulardii: Reported Adverse Effects
Documented safety reports on Saccharomyces Boulardii from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.
Reports by conditionCrohn disease Immunologic
Rarely, oral use of Saccharomyces boulardii has been associated with fungemia in both immunocompromised and immunocompetent patients. Numerous cases of Saccharomyces fungemia have been reported in critically ill intensive care unit (ICU) patients, particularly those with indwelling or central venous catheters, those receiving enteral feeding, or those receiving broad-spectrum antibiotics. Most infections occurred when packets of Saccharomyces were used or when Saccharomyces capsules were opened at the bedside. Admission to the ICU and extended length of stay increase the risk of developing Saccharomyces fungemia. In a hospitalized 1-year-old patient with severe malnutrition and multiple invasive devices, Saccharomyces cerevisiae fungemia developed 2 days after receiving a probiotic containing S. boulardii 200 mg twice daily for 4 days. In addition, there are two case reports of S. cerevisiae fungemia in hospitalized and intubated older patients with COVID-19 who had been given S. boulardii for diarrhea.
The true incidence of fungemia is difficult to determine with S. boulardii. Most clinical laboratories are unable to differentiate between S. boulardii and S. cerevisiae, which might come from other sources. In two case reports of patients in the ICU, there was a 100% alignment of fungal ribosomal DNA ITS sequences between the strains found in the blood of the infected patients and the strains of S. boulardii that had been administered. In a large analysis of hospitalized patients, the incidence rate of Saccharomyces fungemia was 0.11% of those given S. boulardii and did not occur in patients not given this probiotic. Packets or capsules opened at a distance from the patient in the hospital were included in this analysis.
Positive Saccharomyces cultures have also been obtained rarely from other sites, such as the abdominal region and the oral or respiratory tract.
An elevated erythrocyte sedimentation rate may occur when S. boulardii is used to treat Crohn disease, but this effect may be a natural part of the disease process.
- Niault M, Thomas F, Prost J, et al. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clin Infect Dis 1999;28:930.
- Pletinex M, Legein J, Vandenplas Y. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J Pediatr Gastroenterol Nutr 1995;21:113-5.
- Fredenucci I, Chomarat M, Boucaud C, et al. Saccharomyces boulardii fungemia in a patient receiving ultra-levure therapy. Clin Infect Dis 1998;27:222-3.
- Elmer GW, McFarland LV, Surawicz CM, et al. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther 1999;13:1663-8.
- Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 2000;8:504-5.
- Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 2005;40:1625-34.
- Lherm, T., Monet, C., Nougiere, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., and Malbrunot, C. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002;28(6):797-801.
- Riquelme, A. J., Calvo, M. A., Guzman, A. M., Depix, M. S., Garcia, P., Perez, C., Arrese, M., and Labarca, J. A. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin.Gastroenterol. 2003;36(1):41-
- Cherifi, S., Robberecht, J., and Miendje, Y. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis. Acta Clin Belg. 2004;59(4):223-224.
- Ellouze O, Berthoud V, Mervant M, Parthiot JP, Girard C. Septic shock due to Sacccaromyces boulardii. Med Mal Infect. 2016;46(2):104-105.
- Appel-da-Silva MC, Narvaez GA, Perez LRR, Drehmer L, Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Med Mycol Case Rep. 2017;18:15-7.
- Roy U, Jessani LG, Rudramurthy SM, et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses 2017;60(6):375-380.
- Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev Paul Pediatr. 2017 Jul-Sep;35(3):361-364. doi: 10.1590/1984-0462/;2017;35;3;00014.
- Ventoulis I, Sarmourli T, Amoiridou P, et al. Bloodstream infection by Saccharomyces cerevisiae in two COVID-19 patients after receiving supplementation of Saccharomyces in the ICU. J Fungi (Basel). 2020;6(3):98.
- Wombwell E, Bransteitter B, Gillen LR. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic. Mycoses 2021;64(12):1521-1526.
- Rannikko J, Holmberg V, Karppelin M, et al. Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements. Emerg Infect Dis 2021;27(8):2090-6.
- Borriello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003;36:775-80.
- Marteau P, Seksik P. Tolerance of probiotics and prebiotics. J Clin Gastroenterol 2004;38:S67-9.
- Atici S, Soysal A, Karadeniz Cerit K, et al. Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature. Med Mycol Case Rep. 2017;15:33-35.
- Martin IW, Tonner R, Trivedi J, et al. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use. Diagn Microbiol Infect Dis. 2017;87(3):286-8.
- Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev Paul Pediatr 2017;35(3):361-4.
- Hennequin C, Thierry A, Richard GF, et al. Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains. J Clin Microbiol 2001;39:551-9.
- Plein K, Hotz J. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea - a pilot study. Z Gastroenterol 1993;31:129-34.
Flatulence Gastrointestinal
Rarely, oral use of Saccharomyces boulardii has caused gastrointestinal complaints, such as abdominal cramps, flatulence, nausea, vomiting, and decreased appetite.
- Flatley EA, Wilde AM, Nailor MD. Saccharomyces boulardii for the prevention of hospital onset Clostridium difficile infection. J Gastrointestin Liver Dis. 2015;24(1):21-4.
- Awoyemi A, Mayerhofer C, Felix AS, et al. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. EBioMedicine 2021;70:103511.
Adverse-effects data: Natural Medicines, Therapeutic Research Center
Dosing
There is no single official standardized dose for S. boulardii. Products are often measured in milligrams of freeze-dried yeast or in colony-forming units (CFU), and amounts vary widely between brands.
The best approach is to follow the directions on the product label and to choose a reputable brand. Doses used in studies have differed depending on the condition being treated.
Because the right dose and product can depend on your age, health, and reason for use, check with your pharmacist or doctor before starting, especially for children or older adults.
Saccharomyces Boulardii & Pregnancy
Saccharomyces Boulardii & Breastfeeding
© 2026 Therapeutic Research Center
Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center
References & further reading
The 26 references that drive our Saccharomyces Boulardii monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Niault M, Thomas F, Prost J, et al. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clin Infect Dis 1999;28:930.
- Pletinex M, Legein J, Vandenplas Y. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J Pediatr Gastroenterol Nutr 1995;21:113-5. DOI
- Fredenucci I, Chomarat M, Boucaud C, et al. Saccharomyces boulardii fungemia in a patient receiving ultra-levure therapy. Clin Infect Dis 1998;27:222-3.
- Elmer GW, McFarland LV, Surawicz CM, et al. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther 1999;13:1663-8.
- Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998;12:807-22. PubMed
- Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 2000;8:504-5. PubMed
- Hennequin C, Thierry A, Richard GF, et al. Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains. J Clin Microbiol 2001;39:551-9.
- Plein K, Hotz J. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea - a pilot study. Z Gastroenterol 1993;31:129-34.
- Borriello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003;36:775-80. PubMed
- Marteau P, Seksik P. Tolerance of probiotics and prebiotics. J Clin Gastroenterol 2004;38:S67-9. PubMed
- Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 2005;40:1625-34. PubMed
- Lherm, T., Monet, C., Nougiere, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., and Malbrunot, C. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002;28(6):797-801. PubMed
- Riquelme, A. J., Calvo, M. A., Guzman, A. M., Depix, M. S., Garcia, P., Perez, C., Arrese, M., and Labarca, J. A. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin.Gastroenterol. 2003;36(1):41- PubMed
- Cherifi, S., Robberecht, J., and Miendje, Y. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis. Acta Clin Belg. 2004;59(4):223-224. PubMed
- Ellouze O, Berthoud V, Mervant M, Parthiot JP, Girard C. Septic shock due to Sacccaromyces boulardii. Med Mal Infect. 2016;46(2):104-105.
- Appel-da-Silva MC, Narvaez GA, Perez LRR, Drehmer L, Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Med Mycol Case Rep. 2017;18:15-7. PubMed
- Atici S, Soysal A, Karadeniz Cerit K, et al. Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature. Med Mycol Case Rep. 2017;15:33-35. PubMed
- Martin IW, Tonner R, Trivedi J, et al. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use. Diagn Microbiol Infect Dis. 2017;87(3):286-8. PubMed
- Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev Paul Pediatr 2017;35(3):361-4.
- Roy U, Jessani LG, Rudramurthy SM, et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses 2017;60(6):375-380.
- Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev Paul Pediatr. 2017 Jul-Sep;35(3):361-364. doi: 10.1590/1984-0462/;2017;35;3;00014.
- Flatley EA, Wilde AM, Nailor MD. Saccharomyces boulardii for the prevention of hospital onset Clostridium difficile infection. J Gastrointestin Liver Dis. 2015;24(1):21-4. PubMed
- Ventoulis I, Sarmourli T, Amoiridou P, et al. Bloodstream infection by Saccharomyces cerevisiae in two COVID-19 patients after receiving supplementation of Saccharomyces in the ICU. J Fungi (Basel). 2020;6(3):98. PubMed
- Wombwell E, Bransteitter B, Gillen LR. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic. Mycoses 2021;64(12):1521-1526.
- Rannikko J, Holmberg V, Karppelin M, et al. Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements. Emerg Infect Dis 2021;27(8):2090-6.
- Awoyemi A, Mayerhofer C, Felix AS, et al. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. EBioMedicine 2021;70:103511. PubMed
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Brands that make products with Saccharomyces Boulardii
147 brands in our database make a supplement containing Saccharomyces Boulardii.
Supplement products with Saccharomyces Boulardii
611 products in our database contain Saccharomyces Boulardii. Open any to see its full ingredient list and every drug interaction we check.
Saccharomyces Boulardii: Common Questions
What is Saccharomyces Boulardii used for, and does it work?
Does Saccharomyces Boulardii interact with prescription medications?
How are Saccharomyces Boulardii interactions rated?
Is it safe to take Saccharomyces Boulardii with my medications?
Where does this Saccharomyces Boulardii interaction information come from?
What is Saccharomyces Boulardii used for?
Is Saccharomyces Boulardii safe to take?
Can I take it while on antibiotics?
Is it safe during pregnancy or breastfeeding?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Products that contain Saccharomyces Boulardii
A rotating sample of real supplements in our database that list Saccharomyces Boulardii — open any to see its full ingredients and every drug interaction we check.
- Ancient Probiotics Ultimate Once Daily by Ancient Nutrition
- Kids Probiotic Formula Natural Banana Flavor by Garden of Life Primal Defense
- HMF Multi Strain 50 by Genestra Brands
- Probiotic & Prebiotic 30 Billion by Bluebonnet
- Abx Support by Klaire Labs
- Saccharomyces Boulardii 5 Billion CFU by The Vitamin Shoppe
- Truflow Saw Palmetto & Beta-Sitosterol by Force Factor
- Abx Support by Klaire Labs
- FloraMyces by Designs for Health
- Perfect Food Raw by Garden of Life
Have a question about Saccharomyces Boulardii?
Our pharmacists answer your medication & supplement questions — free.